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Academic Department of Surgery, Department of Vascular and Endovascular Surgery, St James’s Hospital,
Dublin 8, Ireland
Objectives: endovascular repair of abdominal aortic aneurysms (E-AAA) has in recent years developed as an alternative
to the conventional open repair (C-AAA). Adverse outcomes following the open approach may relate to immune cell
activation and the systemic inflammatory response syndrome (SIRS) and organ failure but the benefits in this respect of
the endovascular approach are unclear. This study evaluated this question and focused on T-cell activation and function.
Design: prospective clinical study.
Materials: twenty patients undergoing abdominal aortic aneurysm repair (12 C-AAA and 8 E-AAA).
Methods: peripheral T-cell expression of surface markers CD69, CD62L and CD25 in vivo and Interleukin 2 (IL-2) and
Interleukin-10 (IL-10) responses to the superantigen staphylococcal enterotoxin B (SEB) in vitro were measured
preoperatively, 24 h and 1 week postoperatively.
Results: there was no significant increase (p=0.23) in the incidence of SIRS in the open compared with the endovascular
group. Enhanced T cell activation occurred following C-AAA and this was associated with significantly greater IL-2
production in response to SEB, with no change in IL-10 production.
Conclusions: E-AAA attenuates proinflammatory T-cell changes compared with C-AAA repair. A reduction in T-cell
activation and impaired responsiveness to superantigen suggests that the immunological sequelae of the endovascular
approach to aneurysm repair is more favourable than after the open approach with potentially less risk of adverse outcomes.
Proof of this thesis will require a larger prospective study.
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Introduction associated with a marked immunoinflammatory cy-
tokine response and evidence of endotoxaemia.5,6 This
hypothesis, although supported by a compelling ra-Since Parodi’s initial report of intraluminal placement
tionale and some scientific reports,7–10 is unproven atof a stent graft via remote access for abdominal aortic
this time. Indeed, some studies suggest an enhancedaneurysm (AAA) repair in 1991,1 endovascular AAA
immunoinflammatory response to E-AAA repair com-repair (E-AAA) has become an increasingly realistic
pared to open repair, with TNF- and IL-6 implicatedalternative to conventional repair (C-AAA). Large clin-
in its mechanism.11–14ical series and several research studies support both
The T-cell response to injury, and its characteristics,the feasibility of this approach and also benefits con-
either pro-inflammatory or anti-inflammatory, is im-sequent on reduced bowel ischaemia and morbidity,
plicated in the systemic immune response to thesea reduced hospital stay and decreased costs.2–4
stimuli. CD69 is the earliest detectable marker ex-The endovascular approach is, in contrast to the
pressed by activated T-cells. CD25 is part of the IL-2conventional approach, associated with minimal tissue
receptor complex; it reaches maximal expression 48 htrauma, a shorter occlusion time and no bowel hand-
following activation and slowly decreases in ex-ling. It is therefore a reasonable hypothesis that the
pression over the following 72 h. CD62L (L-Selectin)systemic immune, metabolic and inflammatory re-
belongs to the selectin family of cell adhesionsponse to endovascular aneurysm repair may be at-
molecules and its presence identifies regulatory sub-tenuated compared with open repair, which is
populations of T-cells. CD4+/CD62L+ T-cells mediate
the majority of helper functions while CD8+/CD62L+
T-cells include the suppressor cytotoxic subpopulation∗ Please address all correspondence to: J. V. Reynolds, Department
of Surgery, Trinity Centre, St James’s Hospital, Dublin 8, Ireland. of T-cells.
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Table 1. The definition of systemic inflammatory response syn- Peripheral blood mononuclear cell isolation
drome according to the American College of Chest Physicians/
Society of Critical Care Medicine Consensus Conference.18
Peripheral venous blood samples were obtained pre-
Systemic inflammatory response syndrome (SIRS)=the systemic operatively (baseline sample), 24 h postoperatively,
inflammatory response to a variety of severe clinical insults. The and 1 week following surgery (patients dischargedresponse is manifested by two or more of the following conditions:
1. Temperature >38 °C or <36 °C from hospital within 1 week returned to hospital for
2. Heart rate >90 beats per min phlebotomy at 1 week). These were collected in hep-
3. Respiratory rate >20 breaths per min or PaCO2 <32 mmHg arinised tubes, transported on ice and prepared for4. White blood cell count >12 000/cu mm, <4000/cu mm, or
>10% immature (band) forms analysis within one hour of collection. Peripheral blood
mononuclear cells (PBMC) were isolated by a standard
density gradient technique and suspended in RPMI
1640 with Glutamine (Gibco Laboratories) sup-
plemented with antibiotics (penicillin 100 u/ml andThe pro-inflammatory Type 1 helper (Th1) response
streptomycin) and 10% heat inactivated fetal calf serumis characterised by the production of Interleukin 2 (IL-
(Boerhringer-Mannheim, Mannheim, Germany) to a2) and activation of cell-mediated immune responses.15
final concentration of 5×106 cells/ml.The anti-inflammatory Th2 response is associated with
the production of interleukin 10 (IL-10) and antibody
formation.16 The development of either response ap-
pears to depend on the nature of the insult and the
degree of injury. It has recently been suggested that
T-lymphocyte surface marker expressionearly after major injury a Th1 profile predominates.17
The objective of this study was to elucidate the pattern
Expression of cell surface markers on T-cells was de-of T-cell activation following E-AAA and C-AAA and
termined using commercially available fluorescentto describe the differences in cytokine response to each
monoclonal antibodies (PharMigen Europe, U.K.).of the surgical approaches.
Antibodies to three T-cell subpopulation markers were
used: fluorescein isothiocyanate (FITC)-conjugated
mouse anti-human monoclonal antibody to CD3 (T-
cell antigen receptor), CD4 (T-helper cell), and CD8
(cytotoxic/surveillance T-cell). Expression of three T-
Materials and Methods cell activation markers was analysed using R-Phyco-
erythrin (R-PE) conjugated mouse anti-human mono-
Patient population clonal antibody to CD25, CD62L and CD69. Becton
Dickinson Simultest Control1/2a (IgG1 FITC/IgG2a
Twenty patients undergoing elective abdominal aortic PE) was used as a negative control (Becton Dickinson,
aneurysm repair gave informed consent approved by Belgium). Aliquots (100 l) of PBMC suspension were
the St James’s Hospital and Federated Dublin Vol- incubated in dark room conditions with saturating
untary Hospitals Joint Research Ethics Committee. All concentrations of monoclonal antibodies for 15 min at
aneurysms were assessed preoperatively by aorto- room temperature. The cells were washed twice with
graphy and contrast enhanced CT-scanning. Eight Facsflow (Becton Dickinson), fixed with 200 l Cellfix
patients were suitable for E-AAA based on aortic (Becton Dickinson) and stored in darkness at 4 °C.
morphology and 12 patients underwent conventional Flow cytometric analysis was performed within 24 h
C-AAA. A Dacron graft (Brown, U.S.A.) was used of fixing the samples.
in all C-AAA procedures (nine bifurcated and three Lymphocytes were identified by flow cytometry
straight grafts). An Excluder graft (Gore, Germany) (FacScan, Becton Dickinson) using their morphological
was used in 5 E-AAA and a Talent graft (Meditronic, characteristics (forward vs side scatter resolution) and
Germany) was used in 3 E-AAA procedures. All E- gated to exclude granulocytes and monocytes. Non-
AAA grafts were bifurcated. All procedures were per- specific fluorescence was quadranted out using the
formed under general anaesthetic and C-AAA was control antibody and T-cell subpopulations were iden-
performed with additional epidural anaesthesia. An- tified by expression of surface CD3, CD4 or CD8 along
aesthesia and fluid therapy followed a standard pro- the x-axis of a dot plot. Expression of the activation
tocol. The systemic inflammatory response syndrome markers CD25, CD62L and CD69 were read along the
was defined according to the ACCP/SCCM Consensus y-axis. Dual expression was expressed as a percentage
of T-cells with the T-cell subpopulation marker.Conference Committee (Table 1).18
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Age 71 (71–72) 73 (68–79)
ASA 3 (1–4) 2 (1–4)
Duration of surgery (h) 3 (2–7) 3 (2–5)
Operative blood loss (ml) 300 (200–350) 1000 (650–1300)∗
Blood transfused (units) 0 (0–2) 1 (0–4)
Duration ICU/HDU stay (days) 1 (0–1) 4 (2–7)∗
Number of patients developing SIRS 1 4∗
Postoperative hospital stay (days) 4 (3–7) 14 (12–15)∗
ICU/HDU: intensive care unit/high dependency unit; SIRS: systemic inflammatory response syndrome. ∗ p<0.05 vs E-AAA.
Measurement of lymphokine production Results
The cytokine response of patients’ adaptive immune Patients’ demographics and clinical outcome
function was measured using enzyme-linked im-
munoassays. Aliquots (500 l) of patients’ T-cell sus- Patients’ demographics and clinical outcomes are de-
scribed in Table 2. There was no mortality in eitherpensions were incubated for 48 h with an equal volume
of either supplemented RPMI 1640 or Staphylococcus group. E-AAA resulted in significantly reduced hos-
pital stay, reduced ICU/HDU stay and less operativeEnterotoxin B (SEB), a potent T-cell mitogen,16 in sup-
plemented RPMI 1640 at a concentration of 200 ng/ blood loss. There was a decreased incidence of SIRS
in patients treated with E-AAA compared with C-ml. We have found this concentration to be optimal
for stimulation of T-cells (results not shown). Following AAA, however this did not reach statistical significance
(p=0.29). The majority of episodes of SIRS occurredthe incubation the samples were centrifuged at
3000 rpm for 5 min. The resultant supernatant was within the first 72 h of surgery. We observed no dif-
ference in expression of activation marker or cytokinestored at −70 °C until analysed.
ELISA experiments were performed in triplicate production postoperatively between those patients
who experienced episodes of SIRS and those who didusing standard kits to estimate the production of Inter-
leukin 2 (Duotest, Becton Dickinson) and Interleukin not.
10 (Mabtech AB, Sweden). Briefly, ELISA plates (Nunc
Maxisorb, Nunc Nangle International, Denmark) were
coated with capture anti-cytokine antibodies, in-
cubated with 1% BSA, and the unknown samples were Expression of T-cell activation markers
added followed by a biotinylated detection antibody.
Streptavidin-alkaline phosphatase conjugate and A significant increase (Fig. 1) in the number of T cells
expressing CD69 was observed 1 week after surgeryfinally p-nitrophenyl phosphate were then added. An
ELISA reader (Multiskan plus, Labsystems) at an in CD3+ (p=0.02) and CD4+ cells (p=0.035). In marked
contrast, however, there was no significant increase inabsorbency wavelength of 405 nM was used to assess
the alkaline phosphatase activity. expression of CD69 at any time point following E-
AAA (p<0.005 C-AAA vs E-AAA repair at day 7Results were presented as median (inter-quartile
range) and non-parametric statistical testing was used. postoperatively for CD3+ and CD4+ cells). No dif-
ference in expression of CD69 on CD8+ T-cells wasThe data was analysed using SPSS statistical program.
Mann–Whitney U-test was used to compare patients’ observed in either group at any time point. In addition
there was significantly increased expression of CD25demographics and Chi squared test was used to com-
pare incidence of SIRS between the two groups. Kru- (Fig. 2) in the CD3+ subpopulation one week following
C-AAA (p=0.048) and this was significantly increasedskal–Wallis test with Dunn’s post hoc testing was used
for comparison of expression of activation markers compared with E-AAA at one week postoperatively
(p=0.029). There was no significant change in CD62Land cytokine production at the three time points.
p<0.05 was deemed statistically significant. expression in any T-cell subpopulation in either the
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Fig. 2. Expression of CD25 on CD3+ (top graph), CD4+ (middle)Fig. 1. Expression of CD69 on CD3+ (top graph), CD4+ (middle)
and CD8+ (bottom) cells. Expression was significantly increased inand CD8+ (bottom) T-cells. Expression was significantly increased
CD3+ and CD4+ T-cells 1 week following C-AAA. ∗ p<0.05 vsin CD3+ and CD4+ T-cells following C-AAA but not E-AAA 1
preoperative expression of CD25. † p=0.029 vs expression of CD25week postoperatively. ∗ p<0.05 vs preoperative expression of CD69.
on day 7 in E-AAA group.† p<0.005 vs expression of CD69 on day 7 in E-AAA group.
open or endovascular group at any other timepoint
following surgery compared to preoperative levels.
Cytokine production by PBMC
After stimulation in vitro with SEB, PBMCs from
patients undergoing C-AAA produced significantly
greater IL-2 1 week postoperatively (210 (133–548) pg/
Fig. 3. IL-2 production by PBMC stimulated with SEB. Productionml)) compared with preoperative levels (45 (25–64) pg/
was significantly increased 1 week after C-AAA when comparedml) and levels 24 h postoperatively (65 (21–280) pg/
with both preoperative and 1 week post E-AAA production.ml) (Fig. 3). This is in contrast to IL-2 production ∗ p<0.001 vs preoperative production of IL-2. † p=0.048 vs pro-
duction of IL-2 on day 7 post E-AAA.following E-AAA where we failed to observe any
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significant increase in production of IL-2 at any time This observation of T-cell activation does not, how-
point postoperatively, and the differences in IL-2 pro- ever, infer augmented function. Persistent activation
duction following E-AAA and C-AAA became sig- can induce the anergic state implicated in post-
nificant at one week postoperatively (p=0.048). traumatic sepsis and following burns.23 In this study,
There was no difference observed in the production however, anergy was not induced and T-cell function
of IL-10 at any time point in either group. was maintained after both E-AAA and C-AAA.24
Anergy following burn injury has been attributed to
defective expression of the IL-2 receptor and dimin-
ished production of IL-2. In contrast, following either
Discussion endovascular or conventional AAA repair the ex-
pression of interleukin-2 receptor did not diminish
The conventional repair of abdominal aortic an- (and indeed reached significantly increased to sig-
eurysms is associated with a high incidence of post- nificant levels 1 week following C-AAA) and this was
operative systemic inflammation and a significant risk associated with normal or increased production of IL-
of SIRS and organ failure.18 The advent of endoluminal 2 to further stimulation in vitro.
techniques for abdominal aortic aneurysm repair has The cytokine response is evident in both open and
changed the clinical outcome and morbidity from endovascular repairs, but is enhanced in the open
AAA repair without affecting mortality rates.3,4 The versus the endovascular group, consistent with a re-
metabolic, cardiovascular and haematological re- view of the literature to date.25 Cytokines produced
sponse to E-AAA differs considerably to the trans- by normal T-cells in response to the superantigen
peritoneal approach although the effect on systemic staphylococcal enterotoxin (SEB) include IL-2, but not
immune function has not been fully elucidated.20 In IL-10.26 Th2 cells do not mount a normal response tothis study epidural anaesthesia was additionally used SEB and Th1 cells respond in an augmented fashion.in C-AAA, this conceivably may be an influencing In this study a normal production of IL-2 and IL-10
factor but, to the authors knowledge there is no ad- in response to SEB was observed. In contrast, 1 week
ditional effect on T-cell activity of spinal anaesthesia following C-AAA a significantly increased productioncombined with general anaesthetic. The study shows
of IL-2 in vitro without an increase in IL-10 productionthat sustained activation of T-cells and a pro-in-
was noted. An intriguing possibility in man is that C-flammatory Th1 response is associated with the open AAA may facilitate gram-positive translocationrepair and attenuated by the endovascular approach.
through gut hypoxia resulting in “priming” of T-cellsThis early T-cell response is similar to observations in
to a proinflammatory response.27patients after severe trauma and burn injury.21
The behaviour of L-Selectin appears complex fol-The T-cell response to E-AAA differs significantly
lowing AAA repair. Expression of CD62L is indicativefrom C-AAA, with evidence of a sustained expression
of functionally suppressive T-cells (Th2) and is shedof the activation markers CD69 and CD25 in the open
from activated cells.28 No expansion of the CD4+/group compared to the endovascular group. In a recent
CD62L+ T-cell subpopulation following C-AAA oc-study of seven patients treated by E-AAA repair,
curred confirming that a shift to a predominantly Th2Galle et al.10 reported a significant attenuation of T-cell
phenotype had not occurred. Previous studies haveactivation responses in this group compared to an
reported a rapid loss of expression of CD62L on gran-open group (n=5). One of the principle theoretical
ulocytes during E-AAA with restoration of expressionadvantages of E-AAA is avoidance of aortic cross
24 h postoperatively.5 We were unable to demonstrateclamping and attenuation of the ischaemia-reperfusion
any differences in expression of CD62L following E-injury that complicates C-AAA.7 Animal and trans-
AAA. This is unlikely to be due to sample timing asplant models have demonstrated that during isch-
expression of CD69 remained within baseline levelsaemia T-cells become activated, with upregulation of
24 h after surgery suggesting that T-cell activation hadmajor histocompatibility complex (MHC) class II an-
not yet occurred. We conclude that although gran-tigens and production of cytokines including IL-2 and
ulocytes may display transient activation following E-INF.22 In this study significantly increased expression
AAA, T-cell activation occurs by a different mech-of CD69 1 week following C-AAA suggests persistent
anism.postoperative activation of T-cells, a phenomenon not
In conclusion, this report demonstrates significantobserved in the E-AAA group. It is possible that
differences in T-cell response to endovascular andthe absence of cross clamping in the endovascular
transperitoneal approaches to abdominal aortic an-approach and the associated attenuated ischaemia-
reperfusion injury underlies this difference. eurysm repair. Although T-cell responses are enhanced
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comparison between endovascular procedure and conventionalafter both C-AAA and E-AAA repair, the open ap-
surgery. J Vasc Surg 2000; 32: 234–246.
proach is associated with increased activation of T-cells 11 Morikage N, Esato K, Zenpo N, Fujioka K, Takenaka H.
Is endovascular treatment of abdominal aortic aneurysms lessand primes T-cells to an augmented proinflammatory
invasive regarding the biological responses? Surg Today 2000;response to superantigen compared with the en-
30: 142–146.
dovascular approach. Given that we were unable to 12 Hayoz D, Do DD, Mahler F, Triller J, Spertini F. Acute
inflammatory reaction associated with endoluminal bypassdemonstrate a significant difference in T-cell response
grafts. J Endovasc Surg 1997; 4: 354–360.between those who experienced episodes of SIRS and 13 Swartbol P, Norgren L, Albrechtsson U et al. Biological
those who did not, the importance of these findings responses differ considerably between endovascular and con-
ventional aortic aneurysm surgery. Eur J Endovasc Surg 1996; 12:requires further evaluation in a large cohort of patients.
18–25.Nonetheless, the diminished T-cell responses in this 14 Swartbol P, Truedsson L, Norgren L. Adverse reaction during
small series with a trend towards reduced incidence endovascular treatment of aortic aneurysms may be triggered
by interleukin 6 release from the thrombotic content. J Vasc Surgof SIRS supports the thesis that the endovascular
1998; 28: 664–668.
approach attenuates systemic immunoinflammation 15 Henderson B, Poole S, Wilson M. Microbial/host interactions
in health and disease: who controls the cytokine network? Im-compared with the conventional approach, and offers
munopharmacology 1996; 35: 1–21.further scientific rationale for endovascular ap-
16 Klava A, Windsor ACJ, Farmery SM et al. Interleukin-10: a
proaches to aneurysm repair. role in the development of postoperative immunosuppression.
Arch Surg 1997; 132: 425–429.
17 Kell MR, Kavanagh EG, Goebel A, Soberg CC, Lederer JA.
Injury primes the immune system for an enhanced and lethal T-
cell response against bacterial superantigen. Shock 1999; 12:
139–144.
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